著者 | 三村 秀文| 藤原 寛康| 平木 隆夫| 郷原 英夫| 芝本 健太郎| 木股 敬裕| 尾﨑 敏文| 佐々木 了| 金澤 右| |
---|---|
発行日 | 2010-04-01 |
出版物タイトル | 岡山医学会雑誌 |
巻 | 122巻 |
号 | 1号 |
資料タイプ | 学術雑誌論文 |
タイトル(別表記) | Non-vascular interventional radiology for lung cancer |
---|---|
著者 | 平木 隆夫| |
キーワード | 肺癌(lung cancer) インターベンショナルラジオロジー(interventional radiology) 非血管系(non-vascular) |
出版物タイトル | 岡山医学会雑誌 |
発行日 | 2022-12-01 |
巻 | 134巻 |
号 | 3号 |
開始ページ | 145 |
終了ページ | 151 |
ISSN | 0030-1558 |
関連URL | isVersionOf https://doi.org/10.4044/joma.134.145 |
言語 | 日本語 |
著作権者 | Copyright (c) 2022 岡山医学会 |
論文のバージョン | publisher |
DOI | 10.4044/joma.134.145 |
著者 | 平木 隆夫| 安井 光太郎| 三村 秀文| 郷原 英夫| 向井 敬| 長谷 聡一郎| 藤原 寛康| 田尻 展久| 猶本 良夫| 山辻 知樹| 白川 靖博| 浅海 信也| 中塚 秀輝| 花崎 元彦| 森田 潔| 田中 紀章| 金澤 右| |
---|---|
発行日 | 2006-09-01 |
出版物タイトル | 岡山医学会雑誌 |
巻 | 118巻 |
号 | 2号 |
資料タイプ | 学術雑誌論文 |
JaLCDOI | 10.18926/AMO/61429 |
---|---|
フルテキストURL | 75_1_15.pdf |
著者 | Katsui, Kuniaki| Ogata, Takeshi| Tada, Akihiro| Sugiyama, Soichi| Yoshio, Kotaro| Kuroda, Masahiro| Kiura, Katsuyuki| Maeda, Yoshinobu| Toyooka, Shinichi| Hiraki, Takao| Kanazawa, Susumu| |
抄録 | The aim of this study was to investigate whether volumetric positron emission tomography (PET) parameters are prognostic predictors in stage III non-small cell lung cancer patients receiving definitive concurrent chemo-radiotherapy (CCRT) with cisplatin/docetaxel. Cases involving definitive CCRT were reviewed retrospectively, and the maximum standardized uptake value, metabolic tumor volume (MTV) and total lesion glycolysis (TLG) were calculated. The relationships between these PET parameters and prognosis were analyzed. MTV and TLG were significant predictors of distant metastasis-free survival (DMFS) (p = 0.0003 and 0.0005, respectively) and progression-free survival (PFS) (p = 0.001 and 0.0007, respectively). The three-year DMFS rates in patients with low and high MTV were 13.3% and 64.6%, respectively, and the corresponding values in those with low and high TLG were 13.3% and 65.2%, respectively. The three-year PFS rates in patients with low and high MTV were 13.3% and 57.8%, respectively, and the corresponding values in patients with low and high TLG were 13.3% and 57.8%, respectively. However, MTV and TLG were not predictors of local control or overall sur-vival. We demonstrated that volumetric PET parameters were predictors of patients receiving definitive CCRT. Our findings contradict the findings of previous reports and warrant further research to validate them. |
キーワード | volumetric positron emission tomography parameters distant metastasis-free survival chemoradiotherapy cisplatin/docetaxel non-small cell lung cancer |
Amo Type | Original Article |
出版物タイトル | Acta Medica Okayama |
発行日 | 2021-02 |
巻 | 75巻 |
号 | 1号 |
出版者 | Okayama University Medical School |
開始ページ | 15 |
終了ページ | 23 |
ISSN | 0386-300X |
NCID | AA00508441 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
著作権者 | CopyrightⒸ 2021 by Okayama University Medical School |
論文のバージョン | publisher |
査読 | 有り |
PubMed ID | 33649609 |
フルテキストURL | fulltext.pdf |
---|---|
著者 | Matsui, Yusuke| Tomita, Koji| Uka, Mayu| Umakoshi, Noriyuki| Kawabata, Takahiro| Munetomo, Kazuaki| Nagata, Shoma| Iguchi, Toshihiro| Hiraki, Takao| |
キーワード | Ablation Lung Pulmonary Metastasis |
備考 | The version of record of this article, first published in Japanese Journal of Radiology, is available online at Publisher’s website: http://dx.doi.org/10.1007/s11604-022-01302-0| |
発行日 | 2022-07-02 |
出版物タイトル | Japanese Journal of Radiology |
巻 | 40巻 |
号 | 10号 |
出版者 | Springer Science and Business Media LLC |
開始ページ | 1024 |
終了ページ | 1034 |
ISSN | 1867-1071 |
NCID | AA12375935 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
OAI-PMH Set | 岡山大学 |
著作権者 | © The Author(s) 2022 |
論文のバージョン | publisher |
PubMed ID | 35778630 |
DOI | 10.1007/s11604-022-01302-0 |
Web of Science KeyUT | 000819687400001 |
関連URL | isVersionOf https://doi.org/10.1007/s11604-022-01302-0 |
フルテキストURL | fulltext.pdf |
---|---|
著者 | Iwamuro, Masaya| Kawai, Yusuke| Uka, Mayu| Matsui, Yusuke| Hiraki, Takao| Kawahara, Yoshiro| Okada, Hiroyuki| |
発行日 | 2022-04-07 |
出版物タイトル | Case Reports In Gastrointestinal Medicine |
巻 | 2022巻 |
出版者 | Hindawi Ltd. |
開始ページ | 9988216 |
ISSN | 2090-6528 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
OAI-PMH Set | 岡山大学 |
著作権者 | © 2022 Masaya Iwamuro et al. |
論文のバージョン | publisher |
PubMed ID | 35433061 |
DOI | 10.1155/2022/9988216 |
Web of Science KeyUT | 000791234100001 |
関連URL | isVersionOf https://doi.org/10.1155/2022/9988216 |
フルテキストURL | fulltext.pdf |
---|---|
著者 | Yoshio, Kotaro| Ihara, Hiroki| Okamoto, Kazuhiro| Suzuki, Etsuji| Ogata, Takeshi| Sugiyama, Soichi| Nakamura, Keiichiro| Nagao, Shoji| Masuyama, Hisashi| Hiraki, Takao| |
キーワード | cervical cancer tumor size squamous cell carcinoma image-guided brachytherapy (IGBT) central shielding (CS) |
発行日 | 2022-07-05 |
出版物タイトル | Journal Of Radiation Research |
出版者 | Oxford University Press on behalf of The Japanese Radiation Research Society and Japanese Society for Radiation Oncology |
ISSN | 0449-3060 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
OAI-PMH Set | 岡山大学 |
著作権者 | © The Author(s) 2022. |
論文のバージョン | publisher |
PubMed ID | 35791439 |
DOI | 10.1093/jrr/rrac040 |
Web of Science KeyUT | 000820941900001 |
関連URL | isVersionOf https://doi.org/10.1093/jrr/rrac040 |
JaLCDOI | 10.18926/AMO/47265 |
---|---|
フルテキストURL | 65_6_395.pdf |
著者 | Harada, Sosuke| Sato, Shuhei| Suzuki, Etsuji| Okumura, Yoshihiro| Hiraki, Takao| Gobara, Hideo| Mimura, Hidefumi| Kanazawa, Susumu| Kaji, Mitsumasa| Fujiwara, Toshiyoshi| |
抄録 | The aim of the present study was to assess the diagnostic usefulness of Fluorine-18 fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) in the prediction of local recurrence of malignant lung tumors by analyzing the pre-radiofrequency ablation (RFA) maximal standardized uptake value (SUVmax). We performed a historical cohort study of consecutive malignant lung tumors treated by RFA from January 2007 to May 2008 at Okayama University Hospital. We selected only lung tumors examined by PET/CT within 90 days before RFA and divided them (10 primary and 29 metastatic) into 3 groups according to their tertiles of SUVmax. We calculated recurrence odds ratios in the medium group and the high group compared to the low group using multivariate logistic analysis. After we examined the relationship between SUVmax and recurrence in a crude model, we adjusted for some factors. Tumors with higher SUVmax showed higher recurrence odds ratios (medium group;1.84, high group;4.14, respectively). The tumor size also increased the recurrence odds ratio (2.67);we thought this was mainly due to selection bias because we excluded tumors less than 10mm in diameter. This study demonstrated the pre-RFA SUVmax in PET/CT may be a prognostic factor for local recurrence of malignant lung tumors. |
キーワード | fluorodeoxyglucose (FDG) positron emission tomography (PET) standardized uptake value (SUV) radiofrequency ablation (RFA) lung |
Amo Type | Original Article |
出版物タイトル | Acta Medica Okayama |
発行日 | 2011-12 |
巻 | 65巻 |
号 | 6号 |
出版者 | Okayama University Medical School |
開始ページ | 395 |
終了ページ | 402 |
ISSN | 0386-300X |
NCID | AA00508441 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
著作権者 | CopyrightⒸ 2011 by Okayama University Medical School |
論文のバージョン | publisher |
査読 | 有り |
PubMed ID | 22189480 |
Web of Science KeyUT | 000298516900006 |
JaLCDOI | 10.18926/AMO/49669 |
---|---|
フルテキストURL | 67_2_105.pdf |
著者 | Alafate, Aierken| Shinya, Takayoshi| Okumura, Yoshihiro| Sato, Shuhei| Hiraki, Takao| Ishii, Hiroaki| Gobara, Hideo| Kato, Katsuya| Fujiwara, Toshiyoshi| Miyoshi, Shinichiro| Kaji, Mitsumasa| Kanazawa, Susumu| |
抄録 | We retrospectively evaluated the accumulation of fluorodeoxy glucose (FDG) in pulmonary malignancies without local recurrence during 2-year follow-up on positron emission tomography (PET)/computed tomography (CT) after radiofrequency ablation (RFA). Thirty tumors in 25 patients were studied (10 non-small cell lung cancers;20 pulmonary metastatic tumors). PET/CT was performed before RFA, 3 months after RFA, and 6 months after RFA. We assessed the FDG accumulation with the maximum standardized uptake value (SUVmax) compared with the diameters of the lesions. The SUVmax had a decreasing tendency in the first 6 months and, at 6 months post-ablation, FDG accumulation was less affected by inflammatory changes than at 3 months post-RFA. The diameter of the ablated lesion exceeded that of the initial tumor at 3 months post-RFA and shrank to pre-ablation dimensions by 6 months post-RFA. SUVmax was more reliable than the size measurements by CT in the first 6 months after RFA, and PET/CT at 6 months post-RFA may be more appropriate for the assessment of FDG accumulation than that at 3 months post-RFA. |
キーワード | fluorodeoxy glucose (FDG) positron emission tomography (PET) standardized uptake value (SUV) radiofrequency ablation (RFA) non-small cell lung cancer (NSCLC) |
Amo Type | Original Article |
出版物タイトル | Acta Medica Okayama |
発行日 | 2013-04 |
巻 | 67巻 |
号 | 2号 |
出版者 | Okayama University Medical School |
開始ページ | 105 |
終了ページ | 112 |
ISSN | 0386-300X |
NCID | AA00508441 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
著作権者 | CopyrightⒸ 2013 by Okayama University Medical School |
論文のバージョン | publisher |
査読 | 有り |
PubMed ID | 23603927 |
Web of Science KeyUT | 000317801700005 |
関連URL | http://ousar.lib.okayama-u.ac.jp/metadata/50688 |
JaLCDOI | 10.18926/AMO/58270 |
---|---|
フルテキストURL | 74_2_123.pdf |
著者 | Fukuhara, Ryuichiro| Shinya, Takayoshi| Fukuma, Shogo| Ogawa, Nanako| Masaoka, Yoshihisa| Tanaka, Takehiro| Marunaka, Hidenori| Arioka, Tadashi| Hiraki, Takao| Kaji, Mitsumasa| Kanazawa, Susumu| |
抄録 | The aim of this study was to evaluate the ability of pretreatment 90-min 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) to predict the extranodular spread of lymph node metastases in oral squamous cell carcinoma. We retrospectively reviewed the cases of 56 patients who underwent pretreatment 18F-FDG PET/CT and surgery with neck dissection. Maximum standardized uptake value, metabolic tumor volume, and total lesion glycolysis were measured for the 56 primary sites and maximum standardized uptake value was measured for 115 lymph node levels. Extranodular spread was present at 9 lymph node levels in 7 patients. Significant differences were found in metabolic tumor volume and total lesion glycolysis of the primary site, and in lymph node maximum standardized uptake value, between patients with and without extranodular spread (p<0.05). Combining primary site total lesion glycolysis and lymph node maximum standardized uptake volume at their respective optimal cutoffs, the sensitivity, specificity, and accuracy for predicting extranodular spread were 89%, 92%, and 92%, respectively. Pretreatment 18F-FDG PET/CT is useful for predicting extranodular spread in patients with oral squamous cell carcinoma. The combined use of primary site total lesion glycolysis and lymph node maximum standardized uptake value showed greater predictive value than either predictor singly. |
キーワード | 18F-fluorodeoxyglucose positron emission tomography/computed tomography extranodular spread metastasis oral squamous cell carcinoma |
Amo Type | Original Article |
出版物タイトル | Acta Medica Okayama |
発行日 | 2020-04 |
巻 | 74巻 |
号 | 2号 |
出版者 | Okayama University Medical School |
開始ページ | 123 |
終了ページ | 128 |
ISSN | 0386-300X |
NCID | AA00508441 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
著作権者 | CopyrightⒸ 2020 by Okayama University Medical School |
論文のバージョン | publisher |
査読 | 有り |
PubMed ID | 32341586 |
Web of Science KeyUT | 000528278500005 |
NAID | 120006839449 |
JaLCDOI | 10.18926/AMO/54512 |
---|---|
フルテキストURL | 70_4_317.pdf |
著者 | Sakurai, Jun| Matsui, Yusuke| Hiraki, Takao| Iguchi, Toshihiro| Fujiwara, Hiroyasu| Gobara, Hideo| Mitsuhashi, Toshiharu| Nagasaka, Takeshi| Susumu Kanazawa, Susumu Kanazawa| |
抄録 | The present single center prospective phase II clinical trial is designed to evaluate the efficacy and safety of percutaneous radiofrequency (RF) ablation for colorectal lung metastases. Patients who have colorectal lung metastases without extrapulmonary metastases are included in this study. The primary endpoint is 3-year overall survival (OS) after RF ablation. The secondary endpoints are the prevalence of adverse events within 4 weeks, local tumor progression rate, 1- and 5-year OS, cause-specific survival, and relapse-free survival. The recruitment of patients commenced in July 2014, and the enrolment of 45 patients is intended over the 3 years of study period. |
キーワード | radiofrequency ablation colorectal cancer lung metastasis |
Amo Type | Clinical Study Protocols |
出版物タイトル | Acta Medica Okayama |
発行日 | 2016-08 |
巻 | 70巻 |
号 | 4号 |
出版者 | Okayama University Medical School |
開始ページ | 317 |
終了ページ | 321 |
ISSN | 0386-300X |
NCID | AA00508441 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
著作権者 | CopyrightⒸ 2016 by Okayama University Medical School |
論文のバージョン | publisher |
査読 | 有り |
PubMed ID | 27549681 |
Web of Science KeyUT | 000384748600016 |
フルテキストURL | fulltext.pdf |
---|---|
著者 | Katsui, Kuniaki| Ogata, Takeshi| Sugiyama, Soichi| Yoshio, Kotaro| Kuroda, Masahiro| Hiraki, Takao| Kiura, Katsuyuki| Maeda, Yoshinobu| Toyooka, Shinichi| Kanazawa, Susumu| |
発行日 | 2021-06-04 |
出版物タイトル | scientific reports |
巻 | 11巻 |
号 | 1号 |
出版者 | Nature Research |
開始ページ | 11882 |
ISSN | 2045-2322 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
OAI-PMH Set | 岡山大学 |
著作権者 | © The Author(s) 2021 |
論文のバージョン | publisher |
PubMed ID | 34088965 |
DOI | 10.1038/s41598-021-91449-z |
Web of Science KeyUT | 000678611200010 |
関連URL | isVersionOf https://doi.org/10.1038/s41598-021-91449-z |
JaLCDOI | 10.18926/AMO/54509 |
---|---|
フルテキストURL | 70_4_303.pdf |
著者 | Iguchi, Toshihiro| Sakurai, Jun| Hiraki, Takao| Gobara, Hideo| Fujiwara, Hiroyasu| Matsui, Yusuke| Masaoka, Yoshihisa| Kanazawa, Susumu| |
抄録 | This single center prospective study is being conducted to evaluate the safety of the cryoablation for patients with pathologically diagnosed painful bone and soft tissue tumors. Enrollment of 10 patients is planned over the 3-year recruitment period. Patients have related local pain after receiving medications or external radiation therapies will be included in this study. Cryoablation will be percutaneously performed under imaging guidance, and a temperature sensor will be used during treatment as necessary. The primary endpoint is prevalence of severe adverse events within 4 weeks after therapy. The secondary endpoint is effectiveness 4 weeks after the procedure. |
キーワード | cryoablation soft tissue and bone tumor pain safety |
Amo Type | Clinical Study Protocols |
出版物タイトル | Acta Medica Okayama |
発行日 | 2016-08 |
巻 | 70巻 |
号 | 4号 |
出版者 | Okayama University Medical School |
開始ページ | 303 |
終了ページ | 306 |
ISSN | 0386-300X |
NCID | AA00508441 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
著作権者 | CopyrightⒸ 2016 by Okayama University Medical School |
論文のバージョン | publisher |
査読 | 有り |
PubMed ID | 27549678 |
Web of Science KeyUT | 000384748600013 |
フルテキストURL | fulltext20230418-06.pdf |
---|---|
著者 | Umakoshi, Noriyuki| Iguchi, Toshihiro| Matsui, Yusuke| Tomita, Koji| Uka, Mayu| Kawabata, Takahiro| Munetomo, Kazuaki| Nagata, Shoma| Gobara, Hideo| Araki, Motoo| Hiraki, Takao| |
キーワード | Renal cryoablation Transcatheter arterial embolization Chronic kidney disease |
備考 | The version of record of this article, first published in Japanese Journal of Radiology, is available online at Publisher’s website: http://dx.doi.org/10.1007/s11604-023-01416-z| |
発行日 | 2023-04-01 |
出版物タイトル | Japanese Journal of Radiology |
出版者 | Springer Science and Business Media LLC |
ISSN | 1867-1071 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
OAI-PMH Set | 岡山大学 |
著作権者 | © The Author(s) 2023 |
論文のバージョン | publisher |
PubMed ID | 37002430 |
DOI | 10.1007/s11604-023-01416-z |
Web of Science KeyUT | 000961195900001 |
関連URL | isVersionOf https://doi.org/10.1007/s11604-023-01416-z |
JaLCDOI | 10.18926/AMO/66668 |
---|---|
フルテキストURL | 78_1_029.pdf |
著者 | Kitayama, Takahiro| Tanaka, Takashi| Kanie, Yuichiro| Marukawa, Yohei| Kojima, Katsuhide| Tanaka, Takehiro| Takao, Soshi| Hiraki, Takao| |
抄録 | This retrospective study investigated whether necrotic lesions detected on a computed tomography (CT) scan are more regressive than non-necrotic lesions after methotrexate withdrawal in patients pathologically diagnosed with methotrexate-associated lymphoproliferative disorders (MTX-LPD). In total, 89 lesions extracted from 24 patients on CT scans were included in the analysis. All patients had been evaluated for the presence of necrosis within lesions via CT scan upon first suspicion of MTX-LPD (baseline CT scan). The percentage lesion size reduction between the baseline and initial follow-up CT scan was calculated. The association between necrosis within lesions and size changes was estimated via linear regression analyses using both crude and adjusted models. Necrosis was significantly more common in extranodal lesions (27 out of 30 lesions, 90%) than in nodal lesions (9 out of 59 lesions, 15%, p<0.001). In the crude model, the regression of necrotic lesions was 58.5% greater than that of non-necrotic lesions; the difference was statistically significant (p<0.001). Additionally, the longest diameter of necrotic lesions at the baseline CT scan was significantly greater than that of non-necrotic lesions (p<0.001). Based on the adjusted model, necrotic lesions showed 49.3% greater regression than non-necrotic lesions (p=0.017). Necrosis detected on a CT scan was found to be an independent predictor of regression after MTX withdrawal in patients with MTX-LPD. |
キーワード | methotrexate lymphoproliferative disorder computed tomography necrosis |
Amo Type | Original Article |
出版物タイトル | Acta Medica Okayama |
発行日 | 2024-02 |
巻 | 78巻 |
号 | 1号 |
出版者 | Okayama University Medical School |
開始ページ | 29 |
終了ページ | 36 |
ISSN | 0386-300X |
NCID | AA00508441 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
著作権者 | Copyright Ⓒ 2024 by Okayama University Medical School |
論文のバージョン | publisher |
査読 | 有り |
PubMed ID | 38419312 |
JaLCDOI | 10.18926/AMO/32906 |
---|---|
フルテキストURL | fulltext.pdf |
著者 | Mukai, Takashi| Mimura, Hidefumi| Gobara, Hideo| Takemoto, Mitsuhiro| Himei, Kengo| Hiraki, Takao| Hase, Soichiro| Fujiwara, Hiroyasu| Iguchi, Toshihiro| Tajiri, Nobuhisa| Sakurai, Jun| Yasui, Kotaro| Sano, Yoshifumi| Date, Hiroshi| Kanazawa, Susumu| |
抄録 | We report the clinical experience of radiofrequency ablation followed by radiation therapy for large primary lung tumors. Two patients with large primary lung tumors were treated with combined radiofrequency ablation and radiation therapy, and good local control was observed. Combined radiofrequency ablation and radiation therapy that involves minimally invasive techniques appears to be promising for the treatment of large lung tumors. |
キーワード | radiofrequency ablation lung cancer radiation therapy |
Amo Type | Case Report |
出版物タイトル | Acta Medica Okayama |
発行日 | 2007-06 |
巻 | 61巻 |
号 | 3号 |
出版者 | Okayama University Medical School |
開始ページ | 177 |
終了ページ | 180 |
ISSN | 0386-300X |
NCID | AA00508441 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
論文のバージョン | publisher |
査読 | 有り |
PubMed ID | 17593954 |
Web of Science KeyUT | 000247574700008 |
JaLCDOI | 10.18926/AMO/47010 |
---|---|
フルテキストURL | 65_5_287.pdf |
著者 | Hiraki, Takao| Gobara, Hideo| Mimura, Hidefumi| Toyooka, Shinichi| Fujiwara, Hiroyasu| Yasui, Kotaro| Sano, Yoshifumi| Iguchi, Toshihiro| Sakurai, Jun| Tajiri, Nobuhisa| Mukai, Takashi| Matsui, Yusuke| Kanazawa, Susumu| |
抄録 | The application of radiofrequency ablation for the treatment of lung cancer by our group at Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences began in June 2001, and in the present report, we review our 10-year experience with this treatment modality at Okayama University Hospital. The local efficacy of radiofrequency ablation for the treatment of lung cancer depends on tumor size and the type of electrode used, but not on tumor type. An important factor for the prevention of local failure may be the acquisition of an adequate ablative margin. The combination of embolization and radiation therapy enhances the local efficacy. Local failure may be salvaged by repeating the radiofrequency ablation, particularly in small tumors. Survival rates after radiofrequency ablation are quite promising for patients with clinical stage I non-small cell lung cancer and pulmonary metastasis from colorectal cancer, hepatocellular carcinoma, and renal cell carcinoma. The complications caused by radiofrequency ablation can be treated conservatively in the majority of cases. However, attention should be paid to rare but serious complications. This review shows that radiofrequency ablation is a promising treatment for patients with lung cancer. |
キーワード | radiofrequency ablation lung cancer local efficacy survival complication |
Amo Type | Review |
出版物タイトル | Acta Medica Okayama |
発行日 | 2011-10 |
巻 | 65巻 |
号 | 5号 |
出版者 | Okayama University Medical School |
開始ページ | 287 |
終了ページ | 297 |
ISSN | 0386-300X |
NCID | AA00508441 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
著作権者 | CopyrightⒸ 2011 by Okayama University Medical School |
論文のバージョン | publisher |
査読 | 有り |
PubMed ID | 22037265 |
Web of Science KeyUT | 000296116400002 |
フルテキストURL | fulltext.pdf |
---|---|
著者 | Katayama, Norihisa| Katsui, Kuniaki| Watanabe, Kenta| Nagao, Ryota| Otsuki, Kaho| Hiraki, Takao| Kanazawa, Susumu| |
キーワード | Bone metastasis breast cancer (BCa) oligometastatic radiation therapy (RT) stereotactic body radiation therapy (SBRT) |
発行日 | 2020-08 |
出版物タイトル | Translational Cancer Research |
巻 | 9巻 |
号 | 8号 |
出版者 | AME Publoshing Company |
開始ページ | 5096 |
終了ページ | 5101 |
ISSN | 2218-676X |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
OAI-PMH Set | 岡山大学 |
著作権者 | © Translational Cancer Research. All rights reserved. |
論文のバージョン | publisher |
DOI | 10.21037/tcr.2020.01.35 |
Web of Science KeyUT | 000562138400066 |
関連URL | isVersionOf https://doi.org/10.21037/tcr.2020.01.35 |
フルテキストURL | fulltext.pdf |
---|---|
著者 | Katsui, Kuniaki| Ogata, Takeshi| Watanabe, Kenta| Katayama, Norihisa| Kuroda, Masahiro| Kiura, Katsuyuki| Hiraki, Takao| Maeda, Yoshinobu| Toyooka, Shinichi| Kanazawa, Susumu| |
キーワード | cisplatin docetaxel dose-volume histogram non-small cell lung cancer PACIFIC trial radiation pneumonitis |
発行日 | 2020-05-04 |
出版物タイトル | Cancer Medicine |
出版者 | Wiley |
ISSN | 2045-7634 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
OAI-PMH Set | 岡山大学 |
著作権者 | © 2020 The Authors. |
論文のバージョン | publisher |
PubMed ID | 32364685 |
DOI | 10.1002/cam4.3093 |
Web of Science KeyUT | 000530411600001 |
関連URL | isVersionOf https://doi.org/10.1002/cam4.3093 |
JaLCDOI | 10.18926/AMO/51909 |
---|---|
フルテキストURL | fulltext.pdf |
著者 | Mimura, Hidefumi| Kanazawa, Susumu| Yasui, Kotaro| Fujiwara, Hiroyasu| Hyodo, Tsuyoshi| Mukai, Takashi| Dendo, Shuichi| Iguchi, Toshihiro| Hiraki, Takao| Koshima, Isao| Hiraki, Yoshio| |
抄録 | This retrospective study evaluated the safety and efficacy of using polidocanol with X-ray fluoroscopy for percutaneous sclerotherapy of venous malformations of the limbs, head, and neck. The subjects were 16 of 18 patients who presented to our department with venous malformations. Two patients were excluded because they were unlikely to benefit from the treatment. Of the 16 included in the study, 1 could not be treated because of inaccessibility, and another was lost to follow-up. Among the 14 cases that we were able to follow-up, 11 cases had had pain as their primary symptom. Following treatment, this symptom remained unchanged in 1 patient, was improved in 4, and had disappeared in 6; however, there was a recurrence of pain for 3 of these patients. Two patients had sought treatment for cosmetic purposes; following treatment, the lesion disappeared in one and showed a significant reduction in the other. The remaining patient presented with a primary symptom of mouth bleeding, which disappeared following treatment. There were no critical complications. Percutaneous sclerotherapy of venous malformations using polidocanol is safe and effective, and permits repeat treatments. The efficacy is especially good for resolving pain, and complications are minor. It is desirable to use fluoroscopy for these procedures |
キーワード | venous malformation sclerotherapy polidocanol fluoroscopy guidance |
Amo Type | Article |
出版物タイトル | Acta Medica Okayama |
発行日 | 2003-10 |
巻 | 57巻 |
号 | 5号 |
出版者 | Okayama University Medical School |
開始ページ | 227 |
終了ページ | 234 |
ISSN | 0386-300X |
NCID | AA00508441 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
論文のバージョン | publisher |
査読 | 有り |
PubMed ID | 14679400 |
Web of Science KeyUT | 000186186000003 |